← Clinical Evidence

SRC-a9df82a4b70e Alaei P 2025

Evidence source and scope

Effects of dopaminergic medication on upper limb motor function, strength and hand dexterity in people with Parkinson’s disease.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1016/j.prdoa.2025.100400

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Alaei P, Wile DJ, Jakobi JM. Effects of dopaminergic medication on upper limb motor function, strength and hand dexterity in people with Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 2025;13:100400. DOI 10.1016/j.prdoa.2025.100400

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-49-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — Medication and elbow MVC

The abstract confirms 16 PD participants and approximately 4% higher elbow-flexor MVC ON medication, with unchanged electrically induced contractile properties.

Source locator: Primary abstract

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide